Cargando…

Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids

OBJECTIVES: The effect of concomitant steroid use on the antibody response to a SARS-CoV-2 vaccine in patients with prostate cancer (PC) remains unknown. We aimed to evaluate the rates of antispike immunoglobulin G (IgG) antibody response to the BNT162b2 mRNA vaccine in patients with PC using steroi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishii, Noritaka, Hatakeyama, Shingo, Yoneyama, Tohru, Tanaka, Ryuma, Narita, Takuma, Fujita, Naoki, Okamoto, Teppei, Yamamoto, Hayato, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Ohyama, Chikara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Clinical-Prostate cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339980/ https://www.ncbi.nlm.nih.gov/pubmed/36008254 http://dx.doi.org/10.1016/j.urolonc.2022.07.015

Ejemplares similares

Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study
por: Fujita, Naoki, et al.
Publicado: (2023)

Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study)
por: Iwamura, Hiromichi, et al.
Publicado: (2021)

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study
por: Fujita, Naoki, et al.
Publicado: (2023)

Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries
por: Konishi, Sakae, et al.
Publicado: (2021)

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers
por: Soma, Osamu, et al.
Publicado: (2018)

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction
por: Narita, Takuma, et al.
Publicado: (2017)

Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
por: Iwamura, Hiromichi, et al.
Publicado: (2022)

Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
por: Hamano, Itsuto, et al.
Publicado: (2020)

Frailty is a predictor of moderate to severe pain after robot‐assisted laparoscopic prostatectomy: A case‐control study (FRAP study)
por: Momota, Masaki, et al.
Publicado: (2020)

Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab
por: Hamaya, Tomoko, et al.
Publicado: (2023)

Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer
por: Fujita, Naoki, et al.
Publicado: (2022)

Renal metastasis of ovarian granulosa cell tumor
por: Togashi, Kyo, et al.
Publicado: (2022)

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study
por: Hamaya, Tomoko, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients
por: Hamaya, Tomoko, et al.
Publicado: (2022)

Robot‐assisted radical cystectomy in a patient with muscle‐invasive bladder cancer following radiotherapy for prostate cancer
por: Kubota, Yuka, et al.
Publicado: (2019)

N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas
por: Kodama, Hirotake, et al.
Publicado: (2021)

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer
por: Koie, Takuya, et al.
Publicado: (2014)

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery
por: Sato, Tendo, et al.
Publicado: (2016)

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
por: Matsumoto, Teppei, et al.
Publicado: (2019)

Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer
por: Fujita, Naoki, et al.
Publicado: (2023)

Aortic calcification burden predicts deterioration of renal function after radical nephrectomy
por: Fukushi, Ken, et al.
Publicado: (2017)

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents
por: Hamano, Itsuto, et al.
Publicado: (2016)

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis
por: Tanaka, Yoshimi, et al.
Publicado: (2017)

Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study
por: Ozaki, Yusuke, et al.
Publicado: (2023)

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan
por: Koie, Takuya, et al.
Publicado: (2015)

Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy
por: Oishi, Takuya, et al.
Publicado: (2023)

Clinical relevance of aortic calcification in urolithiasis patients
por: Tanaka, Toshikazu, et al.
Publicado: (2017)

Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report
por: Koie, Takuya, et al.
Publicado: (2013)

Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma
por: Okuyama, Yoshiharu, et al.
Publicado: (2021)

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis
por: Koie, Takuya, et al.
Publicado: (2014)

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer
por: Kusaka, Ayumu, et al.
Publicado: (2017)

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer
por: Hamano, Itsuto, et al.
Publicado: (2017)

Narrative review of urinary glycan biomarkers in prostate cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2021)

Gene Expression Changes in Venous Segment of Overflow Arteriovenous Fistula
por: Hashimoto, Yasuhiro, et al.
Publicado: (2013)

The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma
por: Ozaki, Kai, et al.
Publicado: (2021)

A Case of Primary Renal Carcinoid Tumor
por: Tanaka, Toshikazu, et al.
Publicado: (2015)

Robotic cross‐folded U‐configuration intracorporeal ileal neobladder for muscle‐invasive bladder cancer: Initial experience and functional outcomes
por: Koie, Takuya, et al.
Publicado: (2018)

Renal cell carcinoma in a lumbar ectopic kidney
por: Hamano, Itsuto, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jhpg5tqbash6gm84lo69atkm9c